Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bora Lim
CenterThe University of Texas MD Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
196 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico Hematology Oncology Group
Bayamón, Puerto Rico
- Doctors Cancer Center
Manati, Puerto Rico
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
- Proncology
San Juan, Puerto Rico
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Kingman Regional Medical Center
Kingman, Arizona, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
- Saint John'S Cancer Institute
Santa Monica, California, United States
- Epic Care Cyberknife Center
Walnut Creek, California, United States
- Um Sylvester Comprehensive Cancer Center at Aventura
Aventura, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Deerfield Beach
Deerfield Beach, Florida, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Kendall
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Plantation
Plantation, Florida, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Saint Luke'S Cancer Institute - Fruitland
Fruitland, Idaho, United States
- Saint Luke'S Cancer Institute - Meridian
Meridian, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Saint Luke'S Cancer Institute - Nampa
Nampa, Idaho, United States
- Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
- Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, United States
- Saint Luke'S Cancer Institute - Twin Falls
Twin Falls, Idaho, United States
- Advocate Good Shepherd Hospital
Barrington, Illinois, United States
- Advocate Illinois Masonic Medical Center
Chicago, Illinois, United States
- John H Stroger Jr Hospital of Cook County
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Amg Crystal Lake - Oncology
Crystal Lake, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Northwestern Medicine Cancer Center Kishwaukee
DeKalb, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Advocate Sherman Hospital
Elgin, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Sept 2024
- Primary completion
- 4 Apr 2025
- Completion
- 4 Apr 2025
- Last update posted
- 3 Mar 2026
- Registered enrollment
- 1
- Registry id
- NCT05554354
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.